Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
Watch coverage from the CHEST 2019 Annual Meeting for information regarding Pirfenidone in patients with unclassifiable interstitial lung disease. Click here!
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.